You have been told you have cancer in the lining of your renal pelvis or ureter. The medical name is upper tract urothelial carcinoma, or UTUC. It is the same cell type as bladder cancer. The location is what changes the plan. For the full story, see the Upper Tract Urothelial Cancer Patient Guide.
The lining of your renal pelvis, your ureter, and your bladder is all the same tissue. Many of the words you may know from bladder cancer come up here too: papillary, low-grade, high-grade, recurrence. The wall up top is thinner, the kidney sits behind it, and the bladder lining stays after surgery. Those three differences are why the operation and the follow-up look different.
After your biopsy, scan, and urine cytology, your team places UTUC into one of two risk groups. The risk group drives the central choice: try to save the kidney, or take it out. Ask: "Is my UTUC low risk or high risk, and why?"
Laser through a scope to destroy the tumor in place. Or remove a segment of the ureter and reconnect it. Repeat scopes at 3 months and beyond. The kidney stays. The visit schedule is long.
A gel form of the chemo drug mitomycin C. Put into the renal pelvis through a thin catheter. Six weekly treatments. About 6 in 10 had a complete response at 3 months in the main trial. Main side effect: ureter narrowing.
The standard high-risk operation. Removes the whole kidney, the entire ureter, and a small cuff of bladder on that side. Often called RNU. Done open, by laparoscopy, or by robot.
For tumors into muscle or in lymph nodes, the POUT trial showed 4 cycles of platinum chemo after RNU lifted 3-year disease-free survival from 46% to 71%. Some centers now give chemo first, before kidney work drops.
If you have one working kidney already, or your other kidney is weak, keeping the affected side becomes a higher goal even when the cancer is high risk. Ask if staged scope treatment, segmental ureterectomy, or Jelmyto is a fit for you. A second opinion at a high-volume center makes sense here.
UTUC is the urinary cancer most tied to Lynch syndrome, an inherited condition that raises risk of colon, uterine, and other cancers. About 1 to 3 out of 100 UTUC patients have it. Higher (5 to 9 in 100) if you were diagnosed under age 65 or have a family pattern. A positive test changes your other-cancer screens, your family's screens, and your drug options if the cancer ever spreads. Ask for a gene counselor referral if any of this fits you.
The bladder lining stays after upper tract surgery. Cystoscopy at 3 months, then every 3 to 6 months for 2 years, then less often. For most people, this never fully stops.
About 8 to 13 out of 100 patients get a tumor in the opposite upper tract at some point. A belly and pelvis CT runs every 6 to 12 months for the first 2 to 3 years for high-risk disease, then yearly.
A single dose into the bladder within 2 weeks of surgery cuts bladder recurrence in the next year from about 32 in 100 to 17 in 100. Standard care when there is no reason not to give it.
Watch blood pressure. Treat diabetes. Stay hydrated. Skip regular NSAIDs unless cleared. Get a yearly kidney lab test. Tell your team before any new pill or supplement.
Smoking causes about half of UTUC and drives recurrences. Patches, gum, varenicline, bupropion, counseling, and quit lines all work. Ask for a referral.
Plants in the Aristolochia family cause UTUC. If you take anything sold for "kidney support," weight loss, or "detox," bring the bottle to your next visit.
You have heavy visible bleeding with clots. Your flank hurts badly and your temperature is above 100.4 F. You cannot urinate. Your belly hurts severely and you cannot keep anything down. You get new leg swelling, chest pain, or shortness of breath after surgery (possible blood clot). After a Jelmyto treatment: you run a high fever, have severe flank pain, or make clearly less urine on the treated side.
You see blood in your urine between visits, even once. Your flank pain is new. Your treated side has new blockage symptoms. Side effects from chemo or Jelmyto interfere with your daily life. You missed a surveillance appointment and need help rescheduling.
About this information
This is general educational information, not medical advice. It gives a plain-language summary of a condition and its common tests and treatments. The summary is not complete and cannot cover every symptom, medication, side effect, or risk that may apply to you. It is not a substitute for the judgment of a licensed clinician who has examined you and knows your history.
Reading this does not create a doctor-patient relationship with WellPrept or with any clinician who reviewed it. Always talk with your own doctor or care team before you start, stop, or change any test, treatment, or medication. If you think you have a medical emergency, call your local emergency number now.
WellPrept does not endorse any specific test, treatment, or medication as safe or effective for you. To the fullest extent allowed by law, WellPrept and its reviewers make no warranties about this information and are not liable for any decision or action based on it.
© 2026 WellPrept, Inc. All rights reserved.